Functionally, soluble fraktaline has been shown to inhibit microglial activation, suppressing the release of pro-inflammatory cytokines, including TNF-α and IL-1β, as well as the expression of CD68 and CD11b in mice with PD [35,59]. The gene discussed is IL1B; the disease is Parkinson disease.